Benzo(5,6)cycloheptapyridines, compositions and method of use
申请人:SCHERING CORPORATION
公开号:EP0270818A1
公开(公告)日:1988-06-15
Derivatives of benzo[5,6]cyclohepta pyridine, and pharmaceutically acceptable salts and solvates thereof are disclosed, which posses anti-allergic and anti-inflammatory activity. Methods for preparing and using the compounds are also described.
Benzo(5,6)cycloheptapyridines, compositions and methods of use
申请人:SCHERING CORPORATION
公开号:EP0685476A1
公开(公告)日:1995-12-06
Derivatives of benzo[5,6]cyclohepta pyridine, and pharmaceutically acceptable salts and solvates thereof are disclosed, which possess anti-allergic and anti-inflammatory activity. Methods for preparing and using the compounds are also described.
Synthesis and biological evaluation of novel derivatives of desloratadine
作者:Shuai Mu、Xiao-Shuai Xie、Duan Niu、Da-Shuai Zhang、Deng-Ke Liu、Chang-Xiao Liu
DOI:10.1016/j.cclet.2013.03.041
日期:2013.6
Series of novel derivatives of desloratadine designed as arginine vasopressin receptor antagonists were synthesized and structurally characterized by melting points, H-1 NMR and HRMS. Their in vivo diuretic activities were evaluated on rats, and several target compounds showed promising diuretic results, especially compounds 8,18,27 and 31. Further in vitro bonding assay and cAMP assay showed that these compounds had a higher affinity to vasopressin V2 receptor than Via receptor. Our studies indicated that desloratadine may be an active substructure for novel arginine vasopressin receptor antagonist development. (C) 2013 Chang-Xiao Liu. Published by Elsevier B.V. on behalf of Chinese Chemical Society. All rights reserved.
Loratadine and Analogues: Discovery and Preliminary Structure–Activity Relationship of Inhibitors of the Amino Acid Transporter B<sup>0</sup>AT2
B(0)AT2, encoded by the SLC6A15 gene, is a transporter for neutral amino acids that has recently been implicated in mood and metabolic disorders. It is predominantly expressed in the brain, but little is otherwise known about its function. To identify inhibitors for this transporter, we screened a library of 3133 different bioactive compounds. Loratadine, a clinically used histamine H1 receptor antagonist, was identified as a selective inhibitor of B(0)AT2 with an IC50 of 4 μM while being less active or inactive against several other members of the SLC6 family. Reversible inhibition of B(0)AT2 was confirmed by electrophysiology. A series of loratadine analogues were synthesized to gain insight into the structure-activity relationships. Our studies provide the first chemical tool for B(0)AT2.
PIWINSKI, JOHN J.;GANGULY, ASHIT K.;GREEN, MICHAEL J.;VILLANI, FRANK J.;W+
作者:PIWINSKI, JOHN J.、GANGULY, ASHIT K.、GREEN, MICHAEL J.、VILLANI, FRANK J.、W+